Author

Rufina Ezeanowi

Institution: Nigerian Institute of Medical Research

Observed institution: Nigerian Institute of Medical Research

OpenAlex ID: A5120815012

A triple-blinded randomized control trial to evaluate the safety and immunogenicity of fractional doses of COVID-19 vaccines (ChAd0x1, AD26.COV2. S, and BNT162B2) among Nigeria adults: the SIFCoVAN trial

2025 · Adesola Zaidat Musa, Abideen Olurotimi Salako, et al. · Trials

Works count: 1

Citation count:

H-index:

I10-index: